Edition:
United Kingdom

Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

106.07USD
20 Sep 2018
Change (% chg)

$0.33 (+0.31%)
Prev Close
$105.74
Open
$105.61
Day's High
$106.11
Day's Low
$104.22
Volume
1,004,659
Avg. Vol
922,284
52-wk High
$107.81
52-wk Low
$73.70

Latest Key Developments (Source: Significant Developments)

Elanco CEO Jeff Simmons Says Spending 8 Percent Of Sales On Research And Development - CNBC
Thursday, 20 Sep 2018 

Sept 20 (Reuters) - :ELANCO CEO JEFF SIMMONS SAYS SPENDING 8 PERCENT OF SALES ON RESEARCH AND DEVELOPMENT - CNBC.ELANCO CEO JEFF SIMMONS SAYS WITH THE REMAINING SHARES ELI LILLY WILL BE EXITING ELANCO OWNERSHIP IN 2019 - CNBC.  Full Article

Elanco Animal Health Prices IPO Of 62.9 Mln Common Shares At $24.00/Share
Wednesday, 19 Sep 2018 

Sept 19 (Reuters) - Elanco Animal Health Inc::ELANCO ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.ELANCO ANIMAL HEALTH INC SAYS PRICED ITS IPO OF 62.9 MILLION SHARES OF COMMON STOCK AT $24.00 PER SHARE.  Full Article

Elanco Announces Launch Of IPO Roadshow
Thursday, 6 Sep 2018 

Sept 6 (Reuters) - Eli Lilly and Co ::ELANCO ANNOUNCES LAUNCH OF IPO ROADSHOW.ELANCO ANIMAL HEALTH - FOLLOWING IPO, LILLY IS EXPECTED TO HOLD ABOUT 82.3% OF ELANCO.  Full Article

Lilly Endowment Reports Open Market Sale Of 190,000 Shares Of Eli Lilly And Co's Common Stock
Friday, 31 Aug 2018 

Aug 31 (Reuters) - Eli Lilly and Co ::LILLY ENDOWMENT REPORTS OPEN MARKET SALE OF 190,000 SHARES OF ELI LILLY AND CO'S COMMON STOCK AT AVERAGE PRICE OF $105.42/SHARE ON AUGUST 30 - SEC FILING.  Full Article

Adocia Announces Update To Second Arbitration Against Eli Lilly & Co
Thursday, 30 Aug 2018 

Aug 30 (Reuters) - Adocia SA ::ADOCIA ANNOUNCES UPDATE TO SECOND ARBITRATION AGAINST ELI LILLY & COMPANY.ADOCIA SA - PROCEEDINGS REMAIN SET FOR ARBITRATION HEARING IN DEC 2018 AND TRIBUNAL DECISION IS EXPECTED IN 2019.ADOCIA SA - UPDATED AMOUNT OF DAMAGES & OTHER SPECIFIC RELIEF TO ABOUT $ 1.8 BLN.ADOCIA SA - LILLY FILED COUNTERCLAIMS AGAINST ADOCIA SEEKING ABOUT $188 MLN, INCLUDING PREJUDGMENT INTEREST.ADOCIA SA - PROCEEDINGS ARE CONFIDENTIAL AND ADOCIA WILL REPORT FURTHER AS APPROPRIATE.ADOCIA - COUNTERCLAIMS BASED ON ALLEGATION CO "CONCEALED ITS DISCOVERIES AND CONFIDENTIAL INFORMATION" WHICH ARE AT ISSUE IN CO'S CLAIMS.  Full Article

Lilly Endowment Inc Reports Open Market Sale Of 195,000 Shares Of Eli Lilly And Co's Common Stock On Aug 20
Tuesday, 21 Aug 2018 

Aug 21 (Reuters) - :LILLY ENDOWMENT INC REPORTS OPEN MARKET SALE OF 195,000 SHARES OF ELI LILLY AND CO'S COMMON STOCK ON AUG 20 AT AVERAGE PRICE OF $105.9/SHARE –SEC FILING.  Full Article

Elanco Animal Health Files IPO Registration Statement
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Eli Lilly and Co ::ELANCO ANIMAL HEALTH FILES IPO REGISTRATION STATEMENT.ELI LILLY AND CO SAYS IPO OF ELANCO ANIMAL HEALTH IS EXPECTED TO REPRESENT AN OWNERSHIP STAKE OF LESS THAN 20 PERCENT IN ELANCO.  Full Article

Elanco Animal Health Inc Files For IPO Of Up To $100 Mln
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Elanco Animal Health Incorporated::ELANCO ANIMAL HEALTH INCORPORATED FILES FOR IPO OF UP TO $100 MILLION – SEC FILING.ELANCO ANIMAL HEALTH INCORPORATED SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NYSE UNDER THE SYMBOL "ELAN".ELANCO ANIMAL HEALTH INCORPORATED SAYS GOLDMAN SACHS & CO. LLC, J.P. MORGAN, MORGAN STANLEY ARE AMONG UNDERWRITERS TO THE IPO.ELANCO ANIMAL HEALTH INCORPORATED SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE.ELANCO ANIMAL HEALTH INC - "FOLLOWING THE COMPLETION OF THE OFFERING, LILLY WILL CONTINUE TO HAVE SIGNIFICANT CONTROL OVER US FOR A PERIOD OF TIME".  Full Article

Eli Lilly And Co Says Director Jackson Tai Reports Open Market Purchase Of 2,168 Common Shares
Friday, 27 Jul 2018 

July 27 (Reuters) - Eli Lilly and Co ::ELI LILLY AND CO SAYS DIRECTOR JACKSON TAI REPORTS OPEN MARKET PURCHASE OF 2,168 COMMON SHARES AT AVERAGE PRICE OF $95.22PER SHARE ON JULY 26 - SEC FILING.  Full Article

Lilly To Separate Elanco Animal Health With Initial Public Offering
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Eli Lilly and Co ::LILLY TO SEPARATE ELANCO ANIMAL HEALTH WITH INITIAL PUBLIC OFFERING.ELI LILLY AND CO - OFFERING IS EXPECTED TO REPRESENT AN OWNERSHIP STAKE OF LESS THAN 20 PERCENT.ELI LILLY AND CO - PLANS TO DIVEST ITS REMAINING OWNERSHIP THROUGH A TAX-EFFICIENT TRANSACTION.ELI LILLY AND CO - FOR LILLY'S FINANCIAL REPORTING, LILLY WILL CONTINUE TO CONSOLIDATE ELANCO IN ITS FINANCIAL RESULTS.ELI LILLY AND CO - NUMBER OF SHARES TO BE OFFERED AND PRICE RANGE FOR OFFERING HAVE NOT YET BEEN DETERMINED.ELI LILLY AND CO - LILLY PLANS TO DIVEST ITS REMAINING OWNERSHIP THROUGH A TAX-EFFICIENT TRANSACTION.ELI LILLY AND CO - LILLY PLANS TO DIVEST ITS REMAINING OWNERSHIP THROUGH A TAX-EFFICIENT TRANSACTION.ELI LILLY AND CO - COMPANY EXPECTS TO COMPLETE IPO PROCESS DURING SECOND HALF OF 2018.ELI LILLY - IPO EXECUTION IS DEPENDENT UPON BUSINESS AND MARKET CONDITIONS.ELI LILLY - WILL FILE A REGISTRATION STATEMENT IN COMING WEEKS WITH U.S. SEC FOR POTENTIAL IPO OF A MINORITY OWNERSHIP STAKE IN ELANCO AS A SEPARATE CO.  Full Article

Photo

Animal health firm Elanco surges 41 percent on debut

Eli Lilly unit Elanco Animal Health Inc's shares jumped as much as 41 percent on their stock market debut on Thursday, adding to investor enthusiasm for the fast-growing pet healthcare market.